Skip to content

Neuroplasticity: all studies

Page 70 of 178: studies 691 to 700 of 1,772, newest first. Back to the neuroplasticity overview

Research

Reframing distress in oncology: the potential of psychedelic-assisted therapy.

Current opinion in oncology July 1, 2026 Fatima Zohra Moujahid, Olivier Taymans

Psychological and existential distress are common across the cancer trajectory and can impair quality of life, treatment adherence, and family functioning. Although psychosocial and pharmacological interventions provide meaningful support, their overall effects are often modest. This review examines the emerging role of psychedelic-assisted therapy (PAT) as a potential approach to better...

Psychedelics in Mental Health: Opportunities and Challenges.

Brain and Behavior July 1, 2026 Lena K L Oestreich, Nathalie M. Rieser

Psychedelic and substance-assisted therapies are attracting renewed scientific, clinical, and public interest as potential interventions for mental health disorders, particularly treatment-resistant depression, post-traumatic stress disorder, and substance use disorders. However, as the field moves from early efficacy trials toward clinical implementation, major questions remain regarding...

DOI: 10.1002/brb3.71574 (opens in new tab) Full text (opens in new tab) Implementation Mental health Psychedelics Psychotherapy +2

Neuroestimulantes naturales: de rituales ancestrales a terapias de vanguardia

Revista CienciaUANL July 1, 2026 Armando Ordaz‐hernández, M. Corona-Ramírez, Israel Jesús Orlando Guerrero

La psilocibina, presente en los “hongos mágicos”, y la 5-MeO-DMT, secretada por el sapo Incilius alvarius, fueron empleadas ancestralmente en rituales espirituales en México. Hoy, la ciencia las reconoce como terapias prometedoras contra depresión, ansiedad, estrés postraumático y adicciones resistentes a tratamientos convencionales. Actúan sobre receptores de serotonina y estimulan la...

DOI: 10.29105/cienciauanl29.138-5 (opens in new tab) Addiction Mental health Clinical practice Psychotherapist

Psychotherapy and Ketamine: How Does This Combination Affect the Duration of the Antidepressant Effect?

Psychosomatic Medicine and General Practice June 30, 2026 Viacheslav Zaika, Yan Tytarenko

Background. Ketamine provides rapid but short-lived antidepressant effects for treatment-resistant depression (TRD). To prolong this response, ketamine-assisted therapy (KAT) combines the drug's pharmacological effects with psychotherapy. Aim. This study aims to analyze scientific evidence regarding the synergistic interaction between ketamine's pharmacological effects and modern...

Ketamine-Augmented Hypnotherapy

Preprints.org June 30, 2026 Dirk Revenstorf, Joost (j.b.c.) Mertens, Martin Schipplick preprint

The therapeutic use of ketamine and other psychoactive substances in psychiatry is attracting growing research interest, particularly in treatment-resistant depression and related conditions refractory to conventional care. Ketamine exerts direct pharmacological antidepressant effects through NMDA receptor antagonism and downstream neuroplastic mechanisms; its combination with structured...

Psychedelics in treatment-resistant depression: a comprehensive review of mechanisms, clinical evidence, and recommendations.

Neuropsychiatrie June 30, 2026 Cielo A Estela-Fernandez, Reem Mohamed Yousif Elsheikh, Dal Bianco Beatrice et al.

Major depressive disorder (MDD) is a heterogeneous, debilitating disorder. A distinct subgroup within the MDD spectrum is identified to have treatment-resistant depression (TRD). There is an impetus to find alternative treatments for TRD to reduce disease burden and improve quality of life. Psychedelics have been used in the treatment of various psychiatric disorders since the 1950s, with...

Cognitive Quantum Tunneling in Belief Alteration

Journal of Quantum Science of Consciousness June 29, 2026 Fábio Antonio Filipini

The present research revisits the boundaries between quantum mechanics, biological systems and the cognitive structuring of beliefs, taking as a pillar the theoretical propositions of Amit Goswami's monistic idealism.The primary scope lies in articulating how the counterintuitive behaviors of subatomic physics provide a non-dualistic framework for phenomena previously restricted to spiritual...

DOI: 10.69573/jqsc.2026.5.1.89-111 (opens in new tab) Consciousness Counterintuitive Embodied cognition Subatomic particle +8

Neuro-Sufism as an Epistemological Bridge: Integrating Islamic Spirituality and Modern Science

NUKHBATUL ULUM Jurnal Bidang Kajian Islam June 26, 2026 Aprilia Musawamah, Suadi Sa’ad, Masykur Wahid et al.

This study examines the epistemological integration between Sufism and modern neuroscience in response to the persistent dichotomy between religious and scientific knowledge in contemporary Islamic thought. While previous studies have explored the psychological and functional dimensions of spirituality, few have systematically formulated an integrative epistemological framework connecting Sufi...

DOI: 10.36701/nukhbah.v12i1.2975 (opens in new tab) Consciousness Spirituality Sufism Islam +7

Psychedelics and autism spectrum disorder: Mechanistic insights, translational evidence and ethical challenges

Journal of Psychiatric Research June 23, 2026 Júlio César Claudino Dos Santos, Sofia Januário Bolan, Guilherme Lodetti da Silva et al.

Autism spectrum disorder (ASD) is a heterogeneous neurodevelopmental condition characterized by persistent deficits in social communication and interaction, restricted and repetitive patterns of behavior, and sensory processing alterations, frequently accompanied by anxiety, emotional dysregulation, and other psychiatric comorbidities. Despite advances in behavioral and pharmacological...

DOI: 10.1016/j.jpsychires.2026.06.035 (opens in new tab) Autism spectrum disorder Medline Spectrum functional analysis Poison control +3

A Critical Evaluation of the Hypothesis that N,N-Dimethyltryptamine has Endogenous Functions

Zenodo (CERN European Organization for Nuclear Research) June 22, 2026 Ramiro Solis preprint

The human body possesses enzymatic machinery to both synthesize and rapidly degrade N,N-dimethyltryptamine (DMT). This coexistence raises a question: does DMT serve an endogenous function, or is it a metabolic byproduct with no physiological role? DMT is structurally almost identical to serotonin and binds to the same serotonin receptors. Serotonin is universally accepted as a neurotransmitter...

DOI: 10.5281/zenodo.20823985 (opens in new tab) Serotonin Endogeny Endogenous agonist 5-HT Receptor +5